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Abstract 
Background. Cognitive remediation (CR) is an intensive intervention targeting 
cognitive impairment with the aim of improving functioning in people with psychotic 
disorders. Shorter forms of CR based on metacognition and targeting cognitive 
problems awareness may be more appropriate for acute inpatient settings where 
time is limited.     
Objectives. To evaluate the feasibility and acceptability of a new brief course of CR 
targeting cognitive and metacognitive difficulties within an acute inpatient 
psychiatric setting.  
Method. Thirteen male service users with psychosis received a three-week course of 
CR. Participants were assessed at baseline and post-treatment on cognitive 
measures, subjective cognitive complaints, functional impairment, and symptom 
severity. Feasibility was assessed based on engagement, attendance and attrition. 
Acceptability was evaluated through treatment satisfaction. 
Results. Eight participants completed therapy, with 81% session attendance. Therapy 
was considered acceptable, with the majority of participants considering it 
satisfactory. Potential benefit analysis showed a significant post-treatment 
improvement in global cognition and memory. Subjective cognitive complaints did 
not change over time.    
Conclusions. It is feasible to deliver brief CR in an acute inpatient setting. Context of 
delivery and engagement are challenges for optimal therapy implementation. CR 
protocol adaptations made to promote metacognitive competencies may 
compensate for lack of intensive practice.  
 
Keywords: cognitive remediation; metacognition; psychosis; inpatient; acute. 
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Introduction 
Robust evidence has consolidated the notion that cognitive difficulties are common in 
people with schizophrenia and other psychotic disorders (Fioravanti, Bianchi, & Cinti, 
2005; Gold & Harvey, 1993; Heinrichs & Zakzanis, 1998; Kahn & Keefe, 2013; Keefe et al., 
2006; Keefe, 2014; Koren, Seidman, Goldsmith, & Harvey, 2006; Reichenberg & Harvey, 
2007; Tandon, Nasrallah, & Keshavan, 2009), while also being consistent over time and 
across cultures (Schaefer, Giangrande, Weinberger, & Dickinson, 2013). These difficulties 
affect multiple domains and predate the illness onset (Gur et al., 2014; Miles et al., 2014; 
Seidmanet al., 2013). Cognitive impairment is strongly associated with poor illness 
prognosis (Mohamed, et al., 2008), as well as reduced social and occupational functioning 
(Bowie et al., 2008; Harvey, 2013). 
Cognitive remediation therapy (CR) is a psychological therapy aiming to improve 
functioning in people with psychosis by targeting cognitive difficulties. There is now 
strong evidence that CR is effective in improving global cognition, performance in specific 
cognitive domains (primarily working memory, executive functioning and processing 
speed) and functioning (McGurk, Twamley, Sitzer, McHugo, & Mueser 2007; Wykes, 
Huddy, Cellard, McGurk, & Czobor, 2011). Differences in delivery methods, intensity, and 
duration do not seem to affect cognitive outcomes significantly. However, strategy-based 
CR programs can induce greater functional gains compared to protocols prioritizing 
intense practice, possibly due to increased transferability of acquired thinking skills 
(Wykes et al., 2011).    
Mechanisms underlying CR effects have been explored (Wykes & Spaulding, 2011). One 
factor hypothesized to mediate and facilitate transfer of therapeutic gains to real-life 
tasks is metacognition (Lysaker et al., 2010; Wykes et al., 2012), which, in this context, is 
defined as the process responsible for regulating information processing and new 
learning (Cella, Reeder, & Wykes, 2015). Metacognition is considered essential for the 
integration of acquired cognitive skills to daily life functioning. This integration is thought 
to be facilitated by two components: metacognitive knowledge (i.e. knowledge and 
beliefs of the person about their own cognition, their cognitive strengths and difficulties) 
and metacognitive regulation (i.e. ability to monitor one’s own cognitive performance, 
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plan, and evaluate implemented strategies) (Cella et al., 2015). Recent findings suggest 
that these metacognitive competencies are impaired in people with psychotic disorders 
and may influence functioning (Koren et al., 2006; Lysaker et al., 2013; Medalia, Thysen, & 
Freilich, 2008).  
Evidence for such metacognitive problems led to the emergence of metacognitive-
oriented psychological therapies (Briki et al., 2014; Favrod, Maire, Bardy, Pernier, & 
Bonsack, 2011; Moritz et al., 2013; Morrison et al., 2014). CIRCuiTS (Computerized 
Interactive Remediation of Cognition Training for Schizophrenia; Reeder et al., 2015) is a 
CR program explicitly promoting metacognitive components by including strategy use and 
guided practice, whilst retaining the role of the therapist in supporting and targeting 
metacognitive processing. CIRCuiTS has been applied to different mental health settings 
showing good acceptability and ease of use for both service users and clinicians (Cella, 
Reeder, & Wykes, 2016; Cellard et al., 2016; Drake et al., 2014; Reeder et al., 2015). 
However, to date there are no applications of metacognitive informed CR in acute mental 
health services. This may be because traditional CR protocols require high and frequent 
session number.  
CR in the context of acute mental health  
In spite of evidence supporting CR as an effective therapy for the improvement of cognitive 
symptoms in people with schizophrenia (Wykes et al., 2011) and its cost-effectiveness (Patel 
et al., 2010; Reeder et al., 2014), there is only limited research on CR implementation 
methods. It is likely that different mental health settings will require protocol adaptation.  
One such setting is acute wards. These services are designed for short periods of 
hospitalization and one challenge is offering CR in the context of a brief inpatient stay. 
Studies conducted in long-term inpatient settings (Lindenmayer et al., 2008), and 
rehabilitative centres (Vita et al., 2011) have shown promising results for CR in terms of 
improving neuropsychological functioning. However, it remains unclear if CR can be a viable 
and beneficial treatment option for acute inpatient settings.  
The issue of implementing and adapting CR for acute mental health wards fits well with the 
need to improve the availability of psychological interventions in these settings. In the UK, 
health authorities have criticized the limited access to psychological therapies in acute 
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settings (CQC, 2014; Schizophrenia Commission, 2012). Better access to psychological 
therapies has also been requested by service users, carers and health professionals (MIND, 
2011). 
With this in mind, the current study attempted to adapt CIRCuiTS to provide service users in 
acute settings with the opportunity to access CR. We tested a novel protocol of shorter 
duration, as delivering a complete CR course would not have been possible due to short-
term nature of acute admissions (i.e. approximately 28 days). The new protocol attempted 
to compensate for the lack of intensive practice by having a specific emphasis on 
metacognition by promoting strategy use and increasing the awareness of cognitive 
difficulties.  
Aims and hypotheses  
The primary aim of this study is therefore to assess the feasibility and acceptability of a brief 
CR therapy within an acute inpatient setting. The intervention potential benefits are 
assessed as a secondary outcome and due to the brief duration of the intervention we only 
expect limited cognitive benefits. However, we hope this intervention may reduce cognitive 
difficulties, improve the awareness of these difficulties, and potentially provide clients with 
some useful strategies to apply in their everyday life. To this end, this study also examines 
potential changes in self-reported cognitive complaints, as well as whether these changes 
are associated with post-therapy changes in objective cognitive measures. Changes in 
perceived functional impairment are also explored.   
Methods 
Design 
Case series with prospective data collected over a five-month period. All eligible participants 
were offered the intervention. Service users who agreed to participate completed an 
assessment before and after treatment. 
Participants 
Participants were recruited from an inpatient ward within an inner city National Health 
Service (NHS) Foundation Trust between January and June 2015. Inclusion criteria included: 
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aged between 18 and 65 years; an ICD-10 psychosis spectrum diagnosis (World Health 
Organization, 1992); experiencing cognitive difficulties; an expected admission of at least 4-
weeks; a clinical status that allowed participation in the assessment and therapy; a good 
command of English language. Exclusion criteria were: presence or history of neurological 
disorders or head injuries; diagnosis of a learning disability; diagnosis of substance misuse; 
illiteracy or very poor educational background.  
Procedure  
All new ward admissions with a relevant diagnosis were considered as potential participants 
and screened for eligibility. If eligible, potential participants were approached, provided with 
verbal and written information about the study, and asked to provide informed written 
consent. After initial assessment, each participant was assigned to a therapist and offered 
CR. Where participants were discharged early, they were offered the opportunity to return 
to the ward to complete therapy. The study received approval from the local NHS trust 
committee. 
Intervention 
The CR course consisted of six sessions each lasting 45 minutes. Sessions were held twice a 
week for a total of three weeks. Therapy was delivered individually by a therapist and 
supported by CIRCuiTS software. CIRCuiTS uses a graphical representation of a village as a 
virtual environment where participants can practice up to 30 cognitive tasks, each one with 
multiple difficulty levels. During a typical session, six to eight tasks are usually completed. 
CIRCuiTS supports strategy use and promotes the use of metacognitive competencies in a 
number of ways. For example, users are actively prompted to choose from a list of available 
strategies when planning to complete tasks. Before starting a task, users are also required to 
estimate the anticipated level of difficulty and completion time. After task completion, they 
are asked to re-evaluate and reflect upon these elements. This way CIRCuiTS supports the 
uptake of metacognitive regulation by promoting planning, monitoring and revision. 
Metacognition was also targeted by the therapist through supporting personalized goal-
setting, choosing of strategies, and tailoring therapy tasks to target specific cognitive 
domains. Through repeated practice, clients gradually learnt to use strategies spontaneously 
according to task requirements and their own strengths and difficulties. Therapists 
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encouraged the transfer of new skills and strategies to daily life by establishing links 
between CIRCuiTS tasks and real-world activities. Homework was set collaboratively for the 
client to continue practicing in between sessions. Each participant worked with the same 
therapist throughout therapy to ensure the development of a good working alliance.  
Materials 
Cognition. The Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS; Gold, Waltz, Prentice, Morris, & Heerey, 1999; Hobart, Goldberg, Bartko, & 
Gold, 1999) was used for a global cognitive assessment. This has been extensively 
used in studies assessing cognition in people with schizophrenia and other 
psychiatric disorders (Hobart et al., 1999), showing high levels of sensitivity and 
reliability (Gold et al., 1999). The Key Search test from the Behavioural Assessment 
of the Dysexecutive Syndrome (BADS; Norris & Tate, 2010; Wilson, Evans, Emslie, 
Alderman, & Burgess, 1998) was used as a measure of executive functioning.  
Subjective cognitive complaints. The Subjective Scale to Investigate Cognition in 
Schizophrenia (SSTICS; Strip, Caron, Renaud, Pampoulova, & Lecomte, 2003) was 
used to assess the participants’ perception of their cognitive difficulties. It is a 21-
item self-report questionnaire investigating subjective complaints on multiple 
cognitive domains, with higher scores indicating greater perceived difficulties. Its 
psychometric properties in people with psychosis have been extensively validated 
(Lecardeur et al., 2009a; Strip et al., 2003).  
Functioning. Participants functioning was assessed with the Work and Social 
Adjustment Scale Revised (WSAS-R; Zahra et al., 2014). This measures perceived 
difficulties (e.g. inability to work) with higher scores indicating greater functional 
impairment. It has shown strong internal consistency (α > .75) and test-retest 
reliability (Mundt, Marks, Shear, & Greist, 2002).  
Symptoms. The Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962) was 
used to assess positive, negative, and affective symptoms. It is a clinician-rated 
instrument and in this study was completed by the ward treating psychiatrists. It 
consists of 18 items representing different symptom constructs, each one rated from 
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1 (not present) to 7 (extremely severe), and produces an overall score with higher 
scores suggesting more severe clinical symptoms (range = 18-126). 
CR feedback questionnaire. All participants were given a satisfaction questionnaire at 
the end of therapy (Reeder et al., 2015). This consisted of 12 items evaluating the 
experience of CR. A sum of these ratings was computed (range = 10-60), with higher 
scores indicating greater therapy satisfaction.  
Therapy materials. Participants’ attendance, their CR goals, the tasks completed 
during sessions, their ratings for task difficulty and completion time, and the 
strategies implemented were recorded. These were referred to throughout CR by 
the therapist to further support the development of metacognition and collaborative 
working.  
Analysis  
Feasibility and acceptability. The proportion of recruited service users was used as an 
indication of CR feasibility. Attendance and attrition rates were also recorded. In addition we 
assessed therapy protocol implementation through session attendance, session duration 
and task practice per session. Acceptability was assessed through the feedback 
questionnaire.  
Intervention potential benefit. In the benefit analysis we considered only participants 
who attended 50% or more of therapy sessions. Preliminary analyses with one-way 
ANOVA were conducted to control for baseline demographic, clinical and cognitive 
differences among the included and dropped-out participants. Within-group 
differences between baseline and post-treatment were assessed using repeated 
measures ANOVA, controlling for the number of sessions attended. Effect sizes were 
estimated using partial eta-squared (ηp2). The association between changes in 
cognitive and metacognitive outcomes was explored with Pearson's correlation. We 
examined the correlation of outcome measures with therapy-related variables and 
illness-related characteristics. All analyses were conducted using SPSS version 21. All 
tests were two-tailed with a significance level set at 0.05. 
Results 
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Feasibility  
In total, 34 inpatients were approached and assessed for eligibility. Eighteen were 
found to be eligible and offered therapy, with thirteen consenting to participate 
(72%). Three service users denied participation due to a lack of interest in the 
therapy. The remaining two, although considered to be experiencing difficulties with 
cognition, did not report any cognitive complaints and therefore did not consider CR 
a useful intervention (n = 2).  
Of the thirteen participants who started CR, five completed less than 50% of sessions 
and were considered drop-outs (38%). Reasons for this included: an early discharge 
(n = 3), poor engagement (n = 1) or a psychotic relapse (n = 1). These participants 
completed an average of 1.8 (SD 0.4; median = 2) sessions. The remaining eight 
participants met the attendance criteria, completing at least 50% of sessions. Figure 
1 illustrates the recruitment process, therapy completion and drop-outs. 
-- Figure 1 here -- 
Those who completed therapy (n = 8) attended an average of 4.9 sessions (SD 1.3; 
median = 5.5), corresponding to 81% session attendance. Sessions lasted an average 
of 46.1 (SD 10.7) minutes and an average of 7.7 (SD 1.1) tasks was completed per 
session (Table 1).  
-- Table 1 here -- 
Acceptability 
The average score for the therapy satisfaction measure was 47.5 (SD 5.4; n=8). All 
participants stated they felt welcome in therapy, with 87.5% reporting they enjoyed the 
experience of CR and 75% stating they enjoyed coming to the sessions and practicing the 
cognitive tasks. Half of the participants reported CIRCuiTS tasks were difficult (50%), whist 
some (37.5%) stated tasks were too easy for them. The majority thought CR demanded a lot 
of effort (62.5%). All participants felt they were able to ask their therapist for help and that 
they were improving their performance the more they practiced the tasks. The majority of 
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service users (62.5%) found therapy facilitating for daily tasks. Overall, seven out of eight 
participants stated they would recommend CR. 
CR potential benefit analysis 
Participant characteristics. Thirteen service users agreed to receive CR. All were male 
with an average age of 34.5 years (SD 10.8). All were prescribed antipsychotic 
medication as part of their usual treatment. The majority were not in a relationship, 
unemployed, had approximately 10 years of contact with mental health services and 
multiple past admissions, and were of African Caribbean ethnicity which is 
representative of the population served by the trust (Table 2).   
-- Table 2 here -- 
Baseline comparisons. CR completers had comparable clinical symptoms to drop-
outs in BPRS (p < .05). Completers had significantly fewer previous hospitalizations 
(M = 1.88; SD 2.41) compared to those who discontinued CR (M = 7.4; SD 5.32) [F (1, 
11) = 6.706, p = .025]. Included and excluded participants were comparable in all 
cognitive measures except for functioning difficulties as assessed by WSAS-R [F (1, 
11) = 9.652, p = .010]. Drop-outs reported a higher degree of subjective functional 
impairment (M = 20.7; SD = 8.13) compared to completers (M = 8.38; SD = 6. 18).  
Data integrity. Eight service users who were considered treatment completers were 
included in the intervention benefit analysis. No pre or post-therapy data were 
missing. All measures showed good internal consistency both at baseline (RBANS: α= 
.808; SSTICS: α= .839; WSAS-R: α= .838; BPRS: α= .852) and post-treatment (RBANS: 
α= .811; SSTICS: α= .911; WSAS-R: α= .911; BPRS: α=.817). Frequencies and boxplots 
were inspected for entry errors and outlier values. An outlier was detected in four 
measurements (WSAS-R; RBANS Immediate Memory Index; RBANS Visuospatial 
Index; RBANS Attention Index), each referring to a different participant. Thus, 
outliers were not considered results of systematic participant’s behaviour or 
measurement error, and none of the participants were excluded. Relevant analyses 
were conducted both with and without the outlying value. Outlier’s exclusion did not 
affect the significance or the direction in any of the statistical tests. Normality of 
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distributions was assessed and confirmed for all outcome measures using the 
Shapiro-Wilk test. 
Cognition. A main effect of time was found for two cognitive measures: RBANS total 
index [F (1, 7) = 9.736, p = .017, ηp2 = .58] and RBANS immediate memory index [F (1, 
7) = 7.773, p = .027, ηp2 = .52]. Post hoc comparisons using the Bonferroni correction 
indicated a significant mean improvement of 8.25 (median change = 6.5; SD = 7.47; 
Interquartile range [IQR] = 15) for the RBANS total score and a significant mean 
increase of 14 (median change = 13.5; SD = 14.2; IQR = 21.5) for the immediate 
memory score after CR. No significant changes were detected for any other cognitive 
domains although all but one showed changes in the expected direction after CR. 
Number of completed sessions was not found to have a significant effect on 
cognitive outcomes (all p > .05). Pre- and post-intervention mean scores are 
presented in Figure 2. Mean changes, ANOVA results and effect sizes are 
summarized in Table 3. 
-- Figure 2 here – 
 
-- Table 3 here -- 
Awareness of cognitive problems. Subjective cognitive complaints decreased, 
although not significantly, after treatment (mean change = -2.25). Main effect of 
time remained not significant when controlling for symptom severity at baseline and 
change of symptom score (BPRS) from baseline to post-therapy (Figure 3). Post-
treatment change in self-assessed cognitive complaints did not correlate with 
changes in objective cognitive outcomes. Decrease of cognitive complaints and 
symptom reduction in BPRS were also not associated; although post-therapy change 
was in the expected direction for both measures. 
Functioning and symptoms. No differences were found among pre and post-
intervention levels of functional impairment as assessed by WSAS-R. Clinical 
symptoms decreased after CR, however not significantly (mean change = -5.87) 
(Figure 3).  
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-- Figure 3 here -- 
Therapy characteristics and outcomes. The number of tasks completed per session 
was significantly associated with improvement in RBANS immediate memory index (r 
= .872; p = .005) and symptom reduction in BPRS (r = -.733; p = .039). The correlation 
with SSTICS mean change approached significance, suggesting a potential association 
with fewer cognitive complaints (r = -.633; p = .073). No associations were found for 
the number of completed sessions and the total time spent in therapy. 
Discussion 
This study aimed to explore the feasibility and acceptability of a novel, brief, 
metacognition-focused CR delivered in an acute inpatient ward for people with 
psychosis. Findings showed that the adapted form of the intervention was feasible 
and acceptable by service users. Participants who took part in therapy showed 
improvements in global cognition and immediate memory. Cognitive complaints 
showed a reducing trend after therapy; however not statistically significant.  
From the 18 eligible inpatients, 13 (72%) agreed to receive therapy, and 8 (62%) 
attended the minimum number of sessions. Pre-therapy aims were met for session 
duration (i.e. 45 minutes) and number of tasks practiced per session (i.e. 6-8). It is 
difficult to compare this feasibility study to large-scale randomized trials. 
Nevertheless, the drop-out rate (38%) was higher than the average attrition rate of 
15% reported in the most recent meta-analysis (Wykes et al., 2011). Nonetheless, 
only one participant in this study discontinued CR due to poor therapy engagement, 
whilst the rest interrupted due to unstable clinical condition or early discharge.  
Our findings should be interpreted within the context of an acute inpatient 
psychiatric ward. One barrier to engagement was that the therapy was not delivered 
as part of routine clinical practice. Thus, CR occasionally “competed” with other 
clinical activities, such as occupational therapy, patients’ review, and recreational 
activities. Integrating CR into the ward services schedule will benefit treatment 
engagement and session attendance. Three service users were not able to complete 
therapy because of early discharge. This was dependent on bed pressure, resulting in 
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promoting discharge at the earliest possible point. Every effort was made to 
encourage discharged participants to return to the ward to complete therapy, but 
this was difficult in practice due to transport and financial issues. 
Many eligible participants were in the early recovery phase from a psychotic 
episode. This is a challenging illness phase to engage people in psychological 
therapy. Symptoms such as confusion and disorganization, which are common in the 
context of recovery from acute psychosis, have been found to predict poor 
engagement and a sub-optimal response to cognitive training (Vita et al., 2013). In 
our study, several service users reported “mental clouding” and concentration 
difficulties as a reason for disengagement from therapy.   
Intake functioning levels may have also impacted therapy engagement with people 
who dropped-out reporting higher degree of functional impairment. These 
participants had more hospital admissions, a possible indicator of illness chronicity. 
CR effects on cognition have been suggested to be smaller for chronic patients with 
multiple hospitalizations (Bowie, Grossman, Gupta, Oyewumi, & Harvey, 2014). 
Confronting this issue from the early contacts with psychiatric services may 
contribute to develop awareness on functioning problems and improve access to 
psychological therapies for acute inpatient service users. 
Regarding acceptability, service users who engaged in CR found therapy helpful and 
satisfying. The majority reported they would recommend CR to others, while more 
than half felt the training could help them in future everyday activities. These results 
are in line with previous findings from a consumer-led survey on the experience of 
CR (Rose et al., 2008) and CIRCuiTS (Reeder et al., 2015).  
CR was associated with moderate improvements in global cognition and immediate 
memory. Results are in-line with inpatients trials (d'Amato et al., 2010; Lindenmayer 
et al., 2008) and comparable with findings from rehabilitative settings (Vita et al., 
2011). Service users who practiced more tasks per session performed better in 
immediate memory measures post-therapy. This possibly exemplifies how efficient 
use of therapy time might benefit treatment gains and is consistent with the 
strategy-based CR approach from which CIRCuiTS is derived (Reeder et al., 2015). 
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Benefits on cognition did not translate to perceived level of functioning post-
treatment. Optimizing therapy gains transfer is a challenge in CR research (Dickinson 
et al., 2010) and this may be particularly difficult in inpatient psychiatric contexts 
where opportunities for generalization are limited (Medalia & Saperstein, 2013). 
However, receiving CR in an inpatient setting may facilitate the uptake of other 
psychological therapies when service users are discharged. Exploring the augmenting 
potential of CR in outpatients with psychosis on waiting lists for Cognitive 
Behavioural Therapy (CBT), Drake et al. (2014) found that a course of CR prior to CBT 
improved CBT efficiency. CR helped service users achieve the same progress in half 
the CBT sessions compared to those who received CBT alone. 
In line with previous research we found a reduction, albeit non-significant, of 
perceived cognitive problems after CR (Cella et al., 2016; Lecardeur et al., 2009b). 
This can be indicative of a change in metacognitive awareness. However these 
changes are difficult to interpret because, unlike cognition, metacognition cannot be 
understood and examined on a simple “improvement-decline” basis. Changes in 
metacognitive awareness need to be considered in relation to cognitive 
performance. In this study, subjective cognitive complaints decreased over time, 
with objective cognitive performance presenting a general post-treatment 
improvement. This appears as a congruous direction of change between objective 
and subjective measurements following CR, and is in accordance with previous 
findings (Cella, Swan, Medin, Reeder, & Wykes, 2014; Medalia et al., 2008; Strip et 
al., 2003).  
How CR affects metacognitive awareness remains unclear. One hypothesis is that 
metacognition-focused CR facilitates a re-examination of cognitive problems 
experienced by the person and promotes more awareness and better understanding 
of these deficits. Future research needs to explore the direction and extent of 
metacognitive awareness as a possible moderator of change. It is possible in fact 
that intake level of metacognition and readiness to acquire these skills may influence 
the transfer potential of individuals and with it the therapy gain potential. A model 
considering metacognition as a mediator of the relationship among cognitive 
training and completion of therapy goals has been advanced (Cella et al., 2015). 
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Limitations 
There are a number of limitations to this study. Feasibility of the CR intervention was 
suboptimal in relation to recruitment, session attendance, and therapy completion 
rates. Thus, further modifications in the adaptation and delivery of CR for acute 
settings should be considered to improve patient recruitment and retention rates.  
CR results are limited to the restricted sample size and the uncontrolled design. A 
power analysis to determine the sample size was not conducted for this study as the 
primary aim was not to detect the intervention effect size, but its feasibility and 
acceptability. This study did not have a control condition as in the context of the 
study’s primary objective it was deemed clinically inappropriate to have a waiting list 
control group. Future studies attempting similar analyses should also control for the 
moderating effects of participant and treatment characteristics.   
Conclusion 
This study showed that our novel brief course of metacognitive-oriented 
computerized CR was feasible, well accepted by service users with psychosis in an 
acute ward and may lead to some benefits on cognition. Emphasizing metacognitive 
processing can be a strategy to counterbalance constrains of limited contact time 
and therefore limited duration and intensity. Larger pragmatic trials are required to 
assess the effectiveness of metacognitive-oriented CR in inpatients settings and its 
implications for promoting functioning and ultimately recovery.   
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Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.  
Cognitive remediation therapy characteristics (N = 8). 
 Mean (SD) 
Sessions attended 4.9 (1.3) 
Sessions per week 1.76 (1.44) 
Total therapy duration (hours)  3.9 (1.76) 
Average session duration (min) 46.1 (10.7) 
Tasks per session 7.7 (1.1) 
Time between assessments (days) 30.3 (19.8) 
CIRCuiTS feedback questionnaire*   47.5 (5.4) 
Note: *Range= 10 – 60.  
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Table 2.  
Demographic and clinical characteristics (N = 13). 
 N (%) 
Age, mean (SD) 34.5 (10.8) 
Ethnicity  
     Afro-Caribbean  7 (53.7) 
     White 3 (23.2) 
     Asian 2 (15.4) 
     Other 1 (7.7) 
Marital Status  
     Single/Unmarried 11 (84.6) 
     Married 1 (7.7) 
     Separated 1 (7.7) 
Accommodation status   
     Private 5 (38.5) 
     Supported 6 (46.2) 
     Homeless 2 (15.4) 
Employment  
     Paid employment  3 (23.1) 
     Unemployed 9 (69.2) 
     Student 1 (7.7) 
Diagnosis  
     Schizophrenia 5 (38.5) 
     Schizoaffective disorder 5 (38.5) 
     Unspecified psychosis 3 (23.1) 
Admission status  
     Voluntary admission 6 (46.2) 
     MHA Section 2 1 (7.7) 
     MHA Section 3 5 (38.5) 
     MHA Section 37 1 (7.7) 
Age at first contact with  
mental health services. mean (SD) 
 
25.6 (8.1) 
Years in contact with mental  
health services, mean (SD) 
 
10.1 (9.4) 
Age at first admission, mean (SD) 26.9 (8.8) 
Number of previous  
admissions, mean (SD) 
 
4 (4.5) 
BPRS at baseline, mean (SD) 39.1 (11.9) 
Notes: BPRS = Brief Psychiatric Rating Scale;  
MHA = Mental Health Act. 
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Table 3.  
Repeated measures ANOVA, controlling for the number of sessions completed (N=8).  
 Mean change  
(SD) 
F-test.  
Time effect 
 
p 
Effect size. 
Within group (ηp2) 
RBANS Total Scale 8.25 (7.47) 9.736 .017 .58 
RBANS Immediate  
             Memory 
14 (14.02) 7.773 .027 .52 
RBANS Visuospatial / 
             Constructional 
-5.25 (28.69) .268 .62 .03 
RBANS Language 2.75 (12.36) .396 .54 .05 
RBANS Attention 5.87 (11.65) 2.033 .19 .22 
RBANS Delayed 
             Memory 
6.87 (11.55) 2.831 .13 .28 
Key Search test 1.62 (3.88) 1.397 .27 .16 
SSTICS Total -2.25 (10.26) 1.953 .21 - 
WSAS-R Total .0 (6.36) .0 1 - 
BPRS Total -5.87 (14.7) 1.394 .28 - 
Notes: RBANS = Repeatable Battery for the Assessment of Neuropsychological Status;  
SSTICS = Subjective Scale to Investigate Cognition in Schizophrenia; WSAS-R = Work and Social 
Adjustment Scale Revised; BPRS = Brief Psychiatric Rating Scale. 
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Figure captions 
Figure 1. Consort diagram  
 
Figure 2. Means of cognitive measures at baseline and post-treatment 
Figure 3. Means of subjective cognitive difficulties; symptom severity; subjective 
functional impairment and expected improvement at baseline and post-treatment 
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